Personalized Medicine for Mesothelioma and All Cancer Patients May Be the Key

A recent study out of France has some that their trials are pointing towards personalized medicine being a key component in helping to treat mesothelioma patients as well as cancer patients in general.

Researchers from the Gustave Roussy Cancer Campus in Paris found that 199 out of 1,110 patients with advanced cancer, including lung, breast, and bowel cancers, who had their genes mapped and had their treatments tailored according to their specific cancer characteristics realized a “30 percent longer” respite from cancer regrowth compared to their previous therapies…